Senior Advisor Dr. David Moller is based in Boston and has extensive experience in biopharmaceutical R&D. He currently serves as Chief Scientific Officer at Sigilon Therapeutics, a biotechnology company developing a new class of medicines which employs engineered cells for the treatment of chronic diseases – including hemophilia and lysosomal storage diseases. David has 20 […]